Mosseri Marlio Charles 4
4 · Nuvectis Pharma, Inc. · Filed May 13, 2025
Insider Transaction Report
Form 4
Mosseri Marlio Charles
10% Owner
Transactions
- Purchase
Common Stock
2025-05-12$8.11/sh+21,167$171,664→ 2,942,761 total(indirect: By Emerald Hill Ventures SARL SPF.)
Footnotes (2)
- [F1]Reflects the weighted average purchase price. The range of prices for the shares purchased was $8.11 to $8.12. The reporting person effected multiple same-way open market purchase transactions on the same day at different prices through a trade order executed by a broker-dealer. The reporting person reported on a single line all such transactions that occurred within a one-dollar price range. The reporting person hereby undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares purchased at each separate price.
- [F2]Charles Mosseri Marlio is the beneficial owner of Emerald Hill Ventures SARL.